Table 3

Immunohistochemistry results of CK19 and Galectin-3 in papillary thyroid carcinoma (PTC) with or without lymphatic metastasis and other nonmalignant thyroid lesions

nodular goiter

n = 97

Follicular adenoma

N = 54

PTC1

N = 248

PTC2

N = 193


CK19

+

Female

21(21.65)

10(18.52)

202(81.45)

121(62.69)

Male

5(5.15)

3(5.56)

44(17.75)

58(30.05)

-

Female

52(53.61)

30(55.56)

0(0.00)

8(4.15)

Male

19(19.59)

11(20.36)

2(0.80)

6(3.11)

Galectin

+

Female

37(38.15)

19(35.19)

196(79.03)

122(63.21)

Male

14(14.43)

7(12.96)

45(18.14)

64(33.16)

-

Female

36(37.11)

21(38.89)

6(2.43)

7(3.63)

Male

10(10.31)

7(12.96)

1(0.40)

0(0.00)


PTC1: papillary thyroid carcinoma (PTC) without lymphatic metastasis

PTC2: papillary thyroid carcinoma (PTC) with lymphatic metastasis

Song et al. Diagnostic Pathology 2011 6:126   doi:10.1186/1746-1596-6-126

Open Data